Quercetin-derived microbial metabolite DOPAC potentiates CD8+ T cell anti-tumor immunity via NRF2-mediated mitophagy
Cell Metabolism · 2025-12 · 37 (12) · 2438-2454.e8
DOI: 10.1016/j.cmet.2025.09.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Metabolism, 2025-12. Verfasst von Penghu Han und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Qilu Hospital of Shandong University, Advanced Medical Research Institute, Shandong University, Jinan 250012, China. Hauptthemen laut MEDLINE: 3,4-Dihydroxyphenylacetic Acid, CD8-Positive T-Lymphocytes, Mitophagy, Neoplasms, Experimental. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: Shandong Province Natural Science Foundation, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Quercetin, a dietary flavonol, shows promise in cancer prevention, though its effects on the immune compartment within the tumor microenvironment are not fully understood. Here, we identify 3,4-dihydroxyphenylacetic acid (DOPAC), a microbial metabolite of quercetin, as a critical mediator of its anti-tumor effects in a CD8+ T cell-dependent manner. Mechanistically, DOPAC directly binds to Kelch-like epichlorohydrin-associated protein 1 (KEAP1), disrupting its interaction with nuclear factor erythroid 2-related factor 2 (NRF2) and preventing KEAP1-mediated degradation of NRF2 in CD8+ T cells. Elevated NRF2 transcriptionally enhances the expression of B cell lymphoma 2-interacting protein 3, promoting mitophagy and mitochondrial functionality, which improves CD8+ T cell fitness within the tumor microenvironment. Furthermore, DOPAC synergizes with immune checkpoint blockade to suppress tumor growth. Our findings underscore the role of microbial metabolites of dietary nutrients in modulating anti-tumor immune responses, positioning DOPAC as a promising candidate for cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Qilu Hospital of Shandong University, Advanced Medical Research Institute, Shandong University, Jinan 250012, China.
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Shandong University, Jinan 250012, China.
- Department of Gastroenterology, Qilu Hospital of Shandong University, Advanced Medical Research Institute, Shandong University, Jinan 250012, China; Shandong Provincial Clinical Research Center for Digestive Diseases, Q…
- Department of Diagnostics, Medical Integration and Practice Center, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
- Department of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan 250012, China.
- Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), Cheeloo College of Medicine Shandong University, Jinan 250012, China.
Förderung
- Shandong Province Natural Science Foundation
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Han, P., Chu, S., Shen, J., Li, L., Zhang, Y., Wang, S., Chen, Y., Ma, Y., Tang, X., Gao, C., Zheng, X., Xu, B., Wang, Q., Yuan, D., & Li, S. (2025). Quercetin-derived microbial metabolite DOPAC potentiates CD8+ T cell anti-tumor immunity via NRF2-mediated mitophagy. Cell Metabolism, 37(12), 2438-2454.e8. https://doi.org/10.1016/j.cmet.2025.09.010
Vancouver
Han P, Chu S, Shen J, Li L, Zhang Y, Wang S, et al. Quercetin-derived microbial metabolite DOPAC potentiates CD8+ T cell anti-tumor immunity via NRF2-mediated mitophagy. Cell Metabolism. 2025;37(12):2438-2454.e8. doi:10.1016/j.cmet.2025.09.010
BibTeX
@article{Han2025,
author = {Han, Penghu and Chu, Shuzheng and Shen, Jing and Li, Lixiang and Zhang, Yan and Wang, Shiguan and Chen, Yatai and Ma, Yangchun and Tang, Xiaolong and Gao, Chao and Zheng, Xiangyun and Xu, Bowen and Wang, Qiong and Yuan, Detian and Li, Shiyang},
title = {Quercetin-derived microbial metabolite DOPAC potentiates CD8+ T cell anti-tumor immunity via NRF2-mediated mitophagy},
journal = {Cell Metabolism},
year = {2025},
volume = {37},
number = {12},
pages = {2438--2454.e8},
doi = {10.1016/j.cmet.2025.09.010}
}
EUVIMED